Maria D. Chermá | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Maria D. Chermá
Linköping University, Sweden

Maria D. Chermá
Affiliation Linköping University
Country Sweden
Scopus ID 6507872208
Documents 13
Citations 181
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0003-0209-9967

Maria D. Chermá is a researcher associated with the Swedish academic and forensic science research environment. Her publication record reflects contributions to forensic toxicology, analytical chemistry, pharmacokinetics and the investigation of drug metabolism. Her research addresses scientific questions relevant to the detection, interpretation and evaluation of substances in biological specimens. Her documented publications and bibliometric indicators provide the foundation for recognition under the Best Researcher Award category.

Abstract

This academic recognition profile presents Maria D. Chermá’s research activities in medicine and health sciences, with particular emphasis on forensic toxicology and pharmacokinetic investigations. Her scholarly work includes studies examining anabolic androgenic steroids, zopiclone and oxycodone. These subjects demonstrate the relevance of analytical measurement and drug metabolism research to forensic interpretation and public health. The profile considers publication contributions, research visibility and documented academic indicators in relation to the Best Researcher Award.

Keywords

Forensic toxicology; pharmacokinetics; analytical chemistry; drug metabolism; mass spectrometry; substance use; medicine and health sciences; biological specimens; toxicological analysis.

Introduction

Forensic toxicology contributes to healthcare, criminal investigations and scientific understanding of substance exposure. Reliable identification and interpretation of drugs and their metabolites require validated analytical approaches and knowledge of pharmacokinetic processes. Chermá’s identified publications address these interconnected areas through investigations involving biological samples and drug-related measurements. Her work illustrates the importance of combining laboratory research with scientifically supported interpretation of toxicological findings.[3][4]

Research Profile

Her research profile is associated with analytical and forensic investigations of pharmaceutical and other substances. The supplied bibliometric information records 13 documents, 181 citations and an h-index of 8. These indicators offer quantitative perspectives on publication activity and citation visibility. They should be interpreted alongside research quality, methodological relevance, individual contributions and the scientific significance of published findings. Her ORCID identifier provides an additional means of distinguishing her scholarly record.[1][2]

Research Contributions

The identified research themes include:

  • Investigation of anabolic androgenic steroid use within a Swedish forensic population.
  • Pharmacokinetic evaluation of zopiclone and metabolite-to-parent ratios for estimating intake timing.
  • Examination of oxycodone pharmacokinetics and its phase I and phase II metabolites using LC–MS-MS.

Together, these topics demonstrate the importance of analytical toxicology in understanding substance exposure, metabolism and evidence interpretation.[3][4][5]

Publications

Three identified publications illustrate the breadth and continuity of her research interests:

  1. Use of anabolic androgenic steroids in a Swedish forensic population: Associations with substance use and criminal convictions. Drug and Alcohol Dependence, October 2026.
  2. Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake. Journal of Analytical Toxicology, 2026.[4]
  3. Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 2022.[5]

Research Impact

The reported 181 citations and h-index of 8 indicate measurable scholarly visibility. The publication topics also connect laboratory-based research with practical forensic applications, particularly drug identification, exposure assessment and interpretation of biological measurements. Such contributions are relevant to the continuing development of analytical methods and evidence-based toxicological practice. Citation indicators provide useful context but do not independently establish research quality or societal impact.

Award Suitability

Maria D. Chermá’s documented research themes, publication activity and reported citation indicators provide relevant considerations for the Best Researcher Award under the Medicine and Health Sciences category. Her work addresses scientifically important questions in forensic toxicology and pharmacokinetics. The Global Innovation Technologist Awards recognize research contributions, scholarly development and the advancement of knowledge across disciplines. Final award assessment should consider verified authorship, individual research responsibilities and the applicable evaluation criteria.

Conclusion

Maria D. Chermá’s academic profile reflects research engagement in forensic toxicology, analytical chemistry and pharmacokinetic science. Her identified publications address drug metabolism and toxicological investigations with relevance to medicine and forensic applications. The reported bibliometric indicators and documented research themes establish a foundation for consideration in the Best Researcher Award category of the Global Innovation Technologist Awards. Her profile represents the contribution of analytical research to scientific understanding and evidence-based practice.

References

  1. Elsevier. (n.d.). Scopus author details: Maria D. Chermá, Author ID 6507872208. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6507872208
  2. ORCID. (n.d.). Maria D. Chermá: ORCID researcher identifier.
    https://orcid.org/0000-0003-0209-9967
  3. Chermá, M. D., et al. (2026). Use of anabolic androgenic steroids in a Swedish forensic population: Associations with substance use and criminal convictions. Drug and Alcohol Dependence.
    https://doi.org/10.1016/j.drugalcdep.2026.113410
  4. Gomonit, M. M., Nilsson, G. H., Nyström, I., Berglund, L., Kugelberg, F. C., Chermá, M. D., et al. (2026). Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake. Journal of Analytical Toxicology, 50(6).
    https://doi.org/10.1093/jat/bkag032
  5. Truver, M. T., Jakobsson, G., Chermá, M. D., Swortwood, M. J., Gréen, H., & Kronstrand, R. (2022). Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 46(9), 1025–1031.
    https://doi.org/10.1093/jat/bkab123
  6. National Library of Medicine. (2026). Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake.

Jun Hu | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Jun Hu
The First Affiliated Hospital of Shantou University Medical College, China

Jun Hu
Affiliation The First Affiliated Hospital of Shantou University Medical College
Country China
Scopus ID 55712134300
Documents 39
Citations 651
h-index 15
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-1864-4862

Jun Hu is a medical researcher affiliated with The First Affiliated Hospital of Shantou University Medical College, China. His reported scholarly record includes 39 documents, 651 citations and an h-index of 15. These bibliometric indicators provide a quantitative overview of publication activity and citation visibility. His documented publications address clinical questions involving knee osteoarthritis, disparities in treatment outcomes and serious bacterial infections. The Best Researcher Award profile highlights these research contributions within the Medicine and Health Sciences subject area.

Abstract

This academic recognition profile summarizes Jun Hu’s reported research metrics and two 2026 journal articles concerning musculoskeletal health disparities and severe infectious disease. The publications illustrate distinct clinical research themes, including differences in pain and arthroplasty outcomes across racial groups and case-based reporting of group A β-hemolytic streptococcal infection associated with purpura fulminans. Bibliometric figures are presented as supplied and should be checked against the current Scopus author record. [1] [2]

Keywords

Jun Hu; Best Researcher Award; clinical research; medicine; health sciences; knee osteoarthritis; total knee arthroplasty; racial disparities; group A β-hemolytic streptococcus; purpura fulminans; bibliometrics.

Introduction

Medical research contributes to evidence-based practice by examining disease patterns, clinical outcomes and challenges affecting patient care. Research on osteoarthritis can help clarify variation in pain and access to joint replacement, while infectious disease case reports can document serious presentations that warrant clinical attention. Hu’s supplied publication records represent these complementary areas of investigation. The available information supports a focused account of the named studies but does not establish their individual methods or findings beyond the bibliographic details provided. [2] [3]

Research Profile

Hu’s reported scholarly profile comprises 39 documents, 651 citations and an h-index of 15. Together, these indicators describe publication volume, citation activity and a balance of productivity and citation reach. They should be interpreted alongside research quality, authorship contributions, methodological rigor and clinical relevance rather than as standalone measures of merit. His listed affiliation provides institutional context for the recognition profile. The supplied records do not establish a comprehensive account of his research appointments, specialist training or leadership responsibilities.

Research Contributions

The two supplied publications identify different clinical questions. The osteoarthritis article explicitly addresses racial disparities in pain and total knee arthroplasty across disease phenotypes. The infectious disease article reports two cases involving group A β-hemolytic streptococcus and purpura fulminans. Considered together, these topics concern both variation in musculoskeletal care and the documentation of severe infection. Their precise implications require interpretation of the full articles, including study design, results, limitations and clinical context. [2] [3]

Publications

  1. “Racial disparities in pain and total knee arthroplasty across knee osteoarthritis phenotypes.” Frontiers in Aging, published 20 May 2026. [2]
  2. “Group A β-hemolytic streptococcus causing purpura fulminans: two case reports.” Frontiers in Immunology, published 10 February 2026. [3]

Research Impact

The reported citation count and h-index indicate measurable scholarly visibility, although citation totals vary over time and across databases. The listed articles address subjects relevant to clinical research and patient care. A robust assessment of impact would additionally examine citation context, independent uptake, methodological quality, reproducibility and evidence of influence on clinical practice. No specific patient outcomes or changes to medical guidelines can be inferred from the bibliographic information alone. [1]

Award Suitability

The supplied publication record and bibliometric indicators provide relevant material for consideration under the Best Researcher Award at the Global Innovation Technologist Awards. A balanced evaluation should consider originality, the nominee’s verified contribution to each publication, research integrity, clinical relevance and independent evidence of impact. This profile summarizes submitted information and does not itself constitute independent verification or confirmation of an award decision.

Conclusion

Jun Hu’s reported research profile combines established bibliometric indicators with publications addressing osteoarthritis-related disparities and severe bacterial infection. These records provide a basis for reviewing his scholarly activity in medicine and health sciences. Verification of author identity, publication attribution and current citation data remains important for a complete and transparent recognition assessment.

References

  1. Elsevier. (n.d.). Scopus author details: Jun Hu, Author ID 55712134300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55712134300
  2. Frontiers. (2026). Racial disparities in pain and total knee arthroplasty across knee osteoarthritis phenotypes. Frontiers in Aging. DOI: 10.3389/fragi.2026.1819274.
    https://doi.org/10.3389/fragi.2026.1819274
  3. Frontiers. (2026). Group A β-hemolytic streptococcus causing purpura fulminans: two case reports. Frontiers in Immunology. DOI: 10.3389/fimmu.2026.1659910.
    https://doi.org/10.3389/fimmu.2026.1659910
  4. ORCID. (n.d.). Jun Hu: ORCID researcher identifier.
    https://orcid.org/0000-0002-1864-4862
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mercedes Cao Vilariño | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Mercedes Cao Vilariño
Universitary Hospital, Spain

Mercedes Cao Vilariño
Affiliation Universitary Hospital
Country Spain
Scopus ID 57195055799
Documents 5
Citations 15
h-index 3
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Mercedes Cao Vilariño is a researcher associated with medical and health sciences in Spain. Her documented research includes a 2020 publication examining smoking cessation support and carbon monoxide monitoring among kidney transplant patients who smoke. This article presents a research profile and recognition overview for the Research Excellence Award associated with the Global Innovation Technologist Awards. The available bibliographic information and supplied research metrics provide the basis for this summary; further verification is needed to establish a comprehensive publication record and award decision.

Abstract

This profile summarizes the supplied academic indicators and a reported clinical research publication associated with Mercedes Cao Vilariño. The study concerns a randomized clinical trial investigating carbon monoxide monitoring using CO-oximetry and brief anti-smoking advice for kidney transplant recipients who smoke. The topic connects preventive healthcare, tobacco cessation, and the management of health risks in transplant populations. Supplied bibliometric figures list five documents, 15 citations, and an h-index of three; these values should be interpreted according to the source and date of retrieval. [1] [2]

Keywords

Mercedes Cao Vilariño; medicine and health sciences; kidney transplantation; smoking cessation; CO-oximetry; clinical research; preventive medicine; research impact; research excellence.

Introduction

Research excellence in healthcare involves the systematic investigation of clinical questions, evaluation of evidence, and potential translation of findings into practice. Smoking cessation is particularly relevant to patients with complex medical histories, including kidney transplant recipients. Research into brief interventions and objective monitoring methods may inform approaches to identifying tobacco use and supporting cessation. The listed publication provides a specific bibliographic point of reference for understanding this research area. [1]

Research Profile

The supplied profile associates the researcher with a hospital institution in Spain and the subject area of medicine and health sciences. The Scopus author identifier provides a route to reviewing indexed publications and associated citation records. Affiliation details, author-name variants, and profile metrics may change over time; institutional and database records should therefore be consulted for current verification. [2]

Research Contributions

The identified clinical trial addresses two components of smoking-related care: carbon monoxide assessment and brief anti-smoking advice. Its focus on kidney transplant recipients places the investigation within a specialized clinical population. The study title indicates a randomized trial design, although detailed conclusions, sample characteristics, and outcome estimates should be drawn from the full publication rather than inferred from bibliographic metadata alone. [1]

Publications

The supplied record identifies the following publication:

  • “Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke.” International Journal of Medical Sciences, 2020. The supplied record lists Mercedes Cao Vilariño among the authors. [1]

Research Impact

The supplied indicators report five documents, 15 citations, and an h-index of three. Citation counts offer one measure of scholarly visibility, but they do not independently establish research quality, clinical effectiveness, or societal benefit. A fuller assessment would consider study design, methodological rigor, reproducibility, collaboration, and relevance to patient care. These indicators should be checked against the current Scopus record before formal publication. [2]

Award Suitability

The Research Excellence Award profile highlights a documented contribution to clinical research relevant to tobacco cessation and transplant care. Consideration for recognition may include verified publications, methodological contributions, independent evidence of impact, and the candidate’s wider research record. This profile describes award-related recognition context and does not, by itself, confirm that an award has been formally conferred.

Conclusion

Mercedes Cao Vilariño’s supplied research profile includes a clinical publication on smoking-related intervention in kidney transplant patients. The reported bibliometric indicators offer a concise snapshot of scholarly activity, while a complete evaluation requires examination of the publication, current author records, and broader evidence of research contribution. Accurate attribution and transparent verification remain essential to responsible academic recognition.

References

  1. Seijo-Bestilleiro, R., Seoane-Pillado, M. T., Pértega-Díaz, S. D., Cao Vilariño, M., Gil-Guillén, V. F., et al. (2020). Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke.
  2. Elsevier. (n.d.). Scopus author details: Mercedes Cao Vilariño, Author ID 57195055799. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57195055799
  3. International Journal of Medical Sciences. (2020). Journal publication record for the randomized clinical trial on CO-oximetry and smoking cessation advice in kidney transplant patients.
  4. Global Innovation Technologist Awards. (n.d.). Official awards website.
    innovationtechnologist.com/

Daniel Alfaiate | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation Instituto Politécnico de Castelo Branco
Country Portugal
Scopus ID 58158006300
Documents 3
Citations 31
h-index 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-5581-4242

Daniel Alfaiate is a researcher affiliated with the Instituto Politécnico de Castelo Branco whose documented scholarly activity is situated within Medicine and Health Sciences. The available publication record includes research concerning sleep medicine, obstructive sleep apnea (OSA), electroencephalography, hematological outcomes, and psychotropic medication effects on sleep architecture. Bibliographic information identifies three Scopus documents and 31 citations, with a reported h-index of 2.

Abstract

The research profile of Daniel Alfaiate reflects an emerging focus on clinical and physiological dimensions of sleep and neurological assessment. His documented works address OSA, wakefulness electroencephalography, hematocrit and erythrocytosis, and the effects of psychotropic medication on sleep architecture. These subjects connect diagnostic assessment with clinically relevant sleep outcomes and provide a coherent basis for evaluating research activity in Medicine and Health Sciences. [1]

Keywords

Sleep medicine; obstructive sleep apnea; electroencephalography; polysomnography; sleep architecture; psychotropic medication; hematocrit; erythrocytosis; clinical research.

Introduction

Sleep disorders can involve respiratory, neurological, cardiovascular, and behavioral dimensions, making multidisciplinary clinical research particularly relevant. OSA is associated with measurable physiological changes and may require complementary diagnostic approaches. Research examining wakefulness EEG and hematological characteristics contributes to the broader clinical understanding of patients evaluated for sleep-related disorders. [2] [3]

Research Profile

The available record indicates a focused research trajectory around sleep-related clinical investigation. The profile combines observational clinical work with physiological measurement, including polysomnographic assessment and electroencephalographic evaluation. Bibliometric indicators reported for the researcher include three documents, 31 citations, and an h-index of 2. [1]

Research Contributions

The documented publications address complementary aspects of sleep-related medicine. One study examines the relationship between OSA and hematocrit or erythrocytosis, while another evaluates wakefulness EEG in OSA patients. A later article investigates class-specific and cumulative effects of psychotropic medication on sleep architecture using retrospective polysomnographic data. [2] [3] [4]

Publications

  • Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology, 2026. [4]
  • Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing, 2025. [2]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing, 2024. [3]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Research Square, 2024. [5]
  • O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco, 2023. [6]

Research Impact

The reported bibliometric record of 31 citations and an h-index of 2 provides a measurable indication of scholarly visibility. The publications also demonstrate continuity in sleep-related research across 2023–2026, with topics spanning intensive care, OSA assessment, hematological outcomes, and medication-associated changes in sleep architecture. [1]

Award Suitability

For the Best Researcher Award category, the documented record provides evidence of peer-reviewed research activity in a defined medical research area. The combination of recent journal publications, sleep-medicine investigations, and identifiable bibliometric indicators offers an objective basis for consideration. Award assessment should additionally consider authorship roles, methodological quality, peer-review status, broader collaboration, and independent verification of bibliographic records.

Conclusion

Daniel Alfaiate’s documented research activity centers on clinically relevant questions in sleep and neurological assessment. His publications provide a coherent research profile involving OSA, EEG evaluation, hematological outcomes, and polysomnographic investigation. The available bibliometric and publication evidence supports consideration within an academic recognition framework, subject to standard verification procedures.

References

  1. Elsevier. (n.d.). Scopus author details: Daniel Alfaiate, Author ID 58158006300. Scopus.
    https://www.scopus.com/pages/authors/58158006300
  2. Springer Nature. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
    DOI: 10.1007/s11325-025-03330-2
  3. Springer Nature. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
    DOI: 10.1007/s11325-024-03116-y
  4. Elsevier. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
    DOI: 10.1016/j.ejphar.2026.179292
  5. Research Square. (2024). Evaluation of wakefulness electroencephalogram in OSA patients.
    DOI: 10.21203/rs.3.rs-3831506/v1
  6. Instituto Politécnico de Castelo Branco. (2023). O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco.

Mehrdad Esmaeilipour | Biotechnology | Excellence in Innovation Award

Published on by Innovation Technologist

Mr. Mehrdad Esmaeilipour | Biotechnology | Excellence in Innovation Award

Parsa Pardazesh Booshehr Sanaat | Iran 

Mehrdad Esmaeilipour is a dedicated and results-driven electronic engineer with significant expertise in green technology, environmental sustainability, and smart system development. With a robust background in electronic circuit design, plasma systems, and digital health innovations, he plays a leading role in integrating engineering excellence with social impact. He currently contributes as a senior electronics engineer at a company specializing in air and water purification systems and also leads his own successful electronics and IT firm. His entrepreneurial mindset and technical expertise have led to multiple product innovations, including a smart bracelet for visually impaired individuals and several intelligent air purification systems. Additionally, he has made notable contributions to robotics through voluntary academic mentorship and team leadership.

Publication Profile 

Google Scholar

Educational Background 

He holds a bachelor’s and an associate degree in electronics engineering from Islamic Azad University. His educational background also includes foundational studies in electronics at a technical high school. His formal training has been further enhanced by certifications in cybersecurity, solar photovoltaic systems, HSE, robotics, and industrial safety.

Professional Experience 

Mehrdad has accumulated rich professional experience in both industrial and academic contexts. As a senior electronics engineer, he leads the design, development, and quality control of advanced electronic systems for environmental applications. In parallel, he serves as the CEO of an electronics and IT company where he manages cross-functional teams and has overseen the successful execution of security, networking, and software projects. His work also includes mentorship roles within university robotics teams, where he contributes to system design, sensor integration, and control strategies.

Research Interests 

His research focuses on environmental electronics, cold plasma technology, artificial intelligence in healthcare, robotic control systems, electronic data engineering, and smart wearable systems. He is particularly interested in developing sustainable technologies that address real-world challenges through a multidisciplinary approach.

Awards and Honors 

Mehrdad has received numerous international accolades for his engineering innovations and societal impact. These include the Tech Excellence Award, Best Wearable Sensing Technology Award, and Best Innovator Award, among others. He has also earned recognition from academic and professional organizations in both engineering and business domains.

Research Skills 

He possesses strong expertise in electronic circuit design, embedded systems, sensor integration, control systems (including PID and fuzzy logic), and smart system architecture. He is proficient in tools such as Altium Designer and Eagle, and he has demonstrated capability in both hardware and software integration for industrial and research applications. His skills are complemented by project management, analytical reasoning, and interdisciplinary collaboration.

Publications 

  1. Advancements in Cold Plasma Technology for Electronic and Surface Sterilization Applications
    Year: 2025

  2. Design, Construction and Performance Comparison of Fuzzy Logic Controller and PID Controller for Two-Wheel Balance Robot
    Year: 2025

  3. The Utilization of Artificial Intelligence Technologies in the Domain of Electronic Data Engineering
    Year: 2025

  4. Single Miller Compensation with Split Output and Current Amplifier Use in Three Stage Amplifiers to Drive Ultra Large Capacitive Loads
    Year: 2015

Conclusion 

Mehrdad Esmaeilipour exemplifies a forward-thinking engineer who merges technological innovation with a commitment to environmental and social betterment. His extensive practical experience, research output, and leadership across industry and academia reflect his capacity to contribute meaningfully to the advancement of electronic engineering and sustainability-driven technologies.

Monika Prakash | Medical Biotechnology | Best Researcher Award

Published on by Innovation Technologist

Dr. Monika Prakash | Medical Biotechnology | Best Researcher Award

Assistant Professor at Ramaiah Institute of Technology, India

Dr. Monika P is an accomplished academician and researcher with a focus on biotechnology, particularly in cell biology, nanobiotechnology, and wound healing. She is currently an Assistant Professor at the Department of Biotechnology, MS Ramaiah Institute of Technology (MSRIT), Bengaluru, where she has been teaching since November 2016. She has over 7 years of research experience and has contributed significantly to the development of novel therapeutic solutions for chronic wound healing, including research on fibroblasts, myofibroblasts, and phytocompounds.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Biotechnology, Visvesvaraya Technological University (VTU), Belagavi, 2023
  • M.Tech in Biotechnology, M.S. Ramaiah Institute of Technology (Autonomous Institute Affiliated to VTU), Bengaluru, 2014, CGPA: 9.43 (Second topper)
  • B.E. in Biotechnology, M.S. Ramaiah Institute of Technology, Bengaluru, 2011, CGPA: 8.8
  • P.U.C. (12th Standard), Maharani Lakshmi Ammanni College, Bengaluru, 2007, 83.5%
  • S.S.L.C. (10th Standard), Nirmala Rani High School, Bengaluru, 2005, 90.72%

Professional Experience 💼

  • Assistant Professor, Department of Biotechnology, MSRIT, Bengaluru, Nov 2016–Present
  • Over 8 years of teaching experience in various biotechnology-related courses
  • Guided multiple undergraduate and postgraduate student projects in fields like tissue engineering, nanobiotechnology, and chronic wound healing

Research Interests 🔬

  • Cell Biology & Cell Culture: Specialization in fibroblasts, myofibroblasts, and their role in wound healing.
  • Nanobiotechnology: Development of novel nanoformulations and scaffolds, especially for medical applications like chronic wound healing.
  • Phytocompounds: Investigating plant-based compounds for their therapeutic potential in wound healing, particularly for diabetic foot ulcers and burn wounds.
  • Chronic Wound Healing: Focus on developing low-cost, effective solutions for enhancing wound regeneration, especially for non-healing ulcers.

Awards and Honors🏆✨

  • Young Women Research Award (2025), Venus International Foundation
  • Certificate of Excellence for completing “Certified Peer Reviewer Course” from Elsevier Researcher Academy (2021)
  • Best Paper Presentation Award at the International Conference on Functional Materials, Energy, Environment, and Biomedical Applications (2022)
  • Best UG Project Award (2022) and other recognitions for mentoring top student projects
  • Best Technical Project Award from the Government of Karnataka for “Development of Nano-catechin for enhanced Bioavailability” (2014)
  • Publons Academy Graduate (2021), first from the institute

Conclusion🌟

Dr. Monika P is a dynamic academician and researcher with a passion for advancing biotechnology research, particularly in the realm of nanobiotechnology and chronic wound healing. Her strong academic background, extensive research experience, and dedication to student mentorship make her a significant contributor to the field of biotechnology. She has consistently earned recognition for her work and continues to foster innovation in her research and teaching. Through various collaborations and funded research projects, Dr. Monika P is paving the way for advancements in wound healing therapies and sustainable healthcare solutions.

Publications 📚

1. 📝 Monika, Prakash, Anushka Poola, Prithvi Prabhu, Samrat K.
“Key insights into recent advances and challenges in COVID‑19 Management”
Discover Public Health (2025) 22: 15.

2. 🧪 P. Monika, M. N. Chandraprabha, R. Hari Krishna, Vittal Maanya, C. Likhitha, N. Pooja.
“Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies”
Hybrid Advances, 2024.

3. 🔬 Prakash Monika, Hari Krishna Rajan, Chandraprabha MN, Sakshi Shetty, Tanushka Mukherjee, S. Girish Kumar.
“Recent Developments in Green Synthesis of Hydroxyapatite Nanocomposites: Relevance to Biomedical and Environmental Applications”
Green Chemistry Letters and Reviews, 2024 (IF- 6.6, Q1)

4. 💉 Prakash, M. N. Chandraprabha, Vivek Radhakrishnan, Prathik Somayaji, Leah Sabu.
“Therapeutic potential of silkworm sericin in wound healing applications.”
Wound Repair and Regeneration, 2024 (IF-3.8, Q1, H-index – 133).

5. 🧑‍🔬 Monika Prakash, M.N. Chandraprabha, R. Hari Krishna, Harini Satish, S. Girish Kumar.
“Iron oxide nanoparticles for inflammatory bowel disease: Recent advances in diagnosis and targeted drug therapy.”
Applied Surface Science Advances. 2024, 19: 100540 (IF- 7.8, Q1).

6. 🔩 Gowda, Charishma C.; B., Lavanya; M. N., Chandra Prabha; Krishna, R. Hari; P., Monika.
“Bioceramics in Hip and Knee Implants.”
Journal of Mines, Metals & Fuels. 2023, 71 (3): 400-407. (Q4)

7. 🌿 Monika, Prakash, M. N. Chandraprabha, and K. N. Murthy.
“Catechin, epicatechin, curcumin, garlic, pomegranate peel and neem extracts of Indian origin showed enhanced anti-inflammatory potential in human primary acute and chronic wound derived fibroblasts by decreasing TGF-β and TNF-α expression.”
BMC Complementary Medicine and Therapies 23, no. 1 (2023): 1-16. (IF- 3.78, Q1)

8. 🧬 Monika, Prakash, M. N. Chandraprabha, KN Chidambara Murthy, P. Veena Waiker, and Annapoorni Rangarajan.
“Standardized ready-to-use laboratory protocol to isolate primary human wound associated fibroblasts from infected wound samples for clinical applications.”
Journal of Microbiological Methods (2023): 106712. (IF- 2.5, Q3)

9. 🧫 Monika, Prakash, M. N. Chandraprabha, and KN Chidambara Murthy.
“Gene expression studies in primary human acute and chronic wound fibroblasts treated with most popular wound healing phytoextracts.”
South African Journal of Botany 155 (2023): 205-213. (IF- 3.11, Q2).

10. 🔬 Krishna, R. Hari, M. N. Chandraprabha, Prakash Monika, Vishal Chaudhary, and C. Manjunatha.
“Biomolecule conjugated inorganic nanoparticles for biomedical applications: A review.”
Biotechnology and Genetic Engineering Reviews (2022): 1-42. (IF- 4.5, Q1).